Kinetic modelling of passive transport and active efflux of a fluoroquinolone across Caco-2 cells using a compartmental approach in NONMEM

References

• Altenberg GA, Vanoye CG, Horton JK, Reuss L. Unidirectional fluxes of rhodamine 123 in multidrug-resistant cells: Evidence against direct drug extrusion from the plasma membrane. Proceedings of the National Academy of Sciences. USA 1994; 91: 4654–4657
   Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annual Reviews in Pharmacology and Toxicology 1999; 39: 361–398
   PubMed Web of Science ®Google Scholar
• Bermejo M, Merino V, Garrigues TM, Pla Delfina JM, Mulet A, Vizet P, Trouiller G, Mercier C. Validation of a biophysical drug absorption model by the PATQSAR system. Journal of Pharmacology Science 1999; 88: 398–405
   PubMed Web of Science ®Google Scholar
• Bock KW, Eckle T, Ouzzine M, Fournel-Gigleux S. Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells. Biochemistry and Pharmacology 2000; 59: 467–470
   PubMed Web of Science ®Google Scholar
• Chen Y, Pant AC, Simon SM. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells. Cancer Research 2001; 61: 7763–7769
   PubMed Web of Science ®Google Scholar
• Cormet-Boyaka E, Huneau JF, Mordrelle ANBP, Carbon C, Rubistein E, Tomé D. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrobial Agents and Chemotherapy 1988; 42: 2607–2611
   Web of Science ®Google Scholar
• Da Violante G, Zerrouk N, Richard I, Frendo JL, Zhiri A, Li-Khuan R, Tricottet V, Provot G, Chaumeil JC, Arnaud P. Short term Caco-2/TC7 cell culture: Comparison between conventional 21-d and a commercially available III-d system. Biology and Pharmacology Bulletin 2004; 27: 1986–1992
   PubMed Web of Science ®Google Scholar
• Domagala JM. Structure–activity and structure–side-effect relationships for the quinolone antibacterials. Journal of Antimicrobial Chemotherapy 1994; 33: 685–706
   PubMed Web of Science ®Google Scholar
• Doppenschmitt S, Spahn-Langguth H, Regardh CG, Langguth P. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. Journal of Pharmacology Science 1999; 88: 1067–1072
   PubMed Web of Science ®Google Scholar
• Eneroth A, Astrom E, Hoogstraate J, Schrenk D, Conrad S, Kauffmann HM, Gjellan K. Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. European Journal of Pharmacology Science 2001; 12: 205–214
   PubMed Web of Science ®Google Scholar
• Engman HA, Lennernas H, Taipalensuu J, Otter C, Leidvik B, Artursson P. CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. Journal of Pharmacology Science 2001; 90: 1736–1751
   PubMed Web of Science ®Google Scholar
• Gres MC, Julian B, Bourrie M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, Fabre G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: Comparison with the parental Caco-2 cell line. Pharmacology Research 1998; 15: 726–733
   PubMed Web of Science ®Google Scholar
• Guo A, Marinaro W, Hu P, Sinko PJ. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Drug Metabolism and Disposition 2002; 30: 457–463
   PubMed Web of Science ®Google Scholar
• Gutmann H, Fricker G, Torok M, Michael S, Beglinger C, Drewe J. Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharmacology Research 1999; 16: 402–407
   PubMed Web of Science ®Google Scholar
• Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736–749
   PubMed Web of Science ®Google Scholar
• Hill WG, Zeidel ML. Reconstituting the barrier properties of a water-tight epithelial membrane by design of leaflet-specific liposomes. Journal of Biology and Chemistry 2000; 275: 30176–30185
   PubMed Web of Science ®Google Scholar
• Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y. Function and expression of multidrug resistance associated protein family in human colon adenocarcinoma cells (Caco-2). Journal of Pharmacology and Experimental Therapy 2000; 292: 265–270
   PubMed Web of Science ®Google Scholar
• Ho NF, Burton PS, Conradi RA, Barsuhn CL. A biophysical model of passive and polarized active transport processes in Caco-2 cells: Approaches to uncoupling apical and basolateral membrane events in the intact cell. Journal of Pharmacology Science 1995; 84: 21–27
   PubMed Web of Science ®Google Scholar
• Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM, Sarkadi B. Fluorescent cellular indicators are extruded by the multidrug resistance protein. Journal of Biology and Chemistry 1993; 268: 21493–21496
   PubMed Web of Science ®Google Scholar
• Hu M, Chen J, Tran D, Zhu Y, Leonardo G. The Caco-2 cell monolayers as an intestinal metabolism model: Metabolism of dipeptide Phe-Pro. Journal of Drug Targets 1994a; 2: 79–89
   PubMed Web of Science ®Google Scholar
• Hu M, Chen J, Zhu Y, Dantzig AH, Stratford REJ, Kuhfeld MT. Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2). Pharmacology Research 1994b; 11: 1405–1413
   PubMed Web of Science ®Google Scholar
• Huynh-Delerme C, Huet H, Noel L, Frigieri A, Kolf-Clauw M. Increased functional expression of P-glycoprotein in Caco-2 TC7 cells exposed long-term to cadmium. Toxicology In Vitro 2005; 19: 439–447
   PubMed Web of Science ®Google Scholar
• Ito S, Woodland C, Sarkadi B, Hockmann G, Walker SE, Koren G. Modeling of P-glycoprotein-involved epithelial drug transport in MDCK cells. American Journal of Physiology 1999; 277: F84–F96
   PubMed Web of Science ®Google Scholar
• Ito T, Yano I, Tanaka K, Inui KI. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1. Journal of Pharmacology and Experimental Therapy 1997; 282: 955–960
   PubMed Web of Science ®Google Scholar
• Karlsson J, Kuo SM, Ziemniak J, Artursson P. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: Mediation of secretion by multiple transporters including P-glycoprotein. British Journal of Pharmacology 1993; 110: 1009–1016
   PubMed Web of Science ®Google Scholar
• Krylov AV, Pohl P, Zeidel ML, Hill WG. Water permeability of asymmetric planar lipid bilayers: Leaflets of different composition offer independent and additive resistances to permeation. Journal of General Physiology 2001; 118: 333–340
   PubMed Web of Science ®Google Scholar
• Lande MB, Priver NA, Zeidel ML. Determinants of apical membrane permeabilities of barrier epithelia. American Journal of Physiology 1994; 267: C367–C374
   PubMed Web of Science ®Google Scholar
• Lennernas H. Human jejunal effective permeability and its correlation with preclinical drug absorption models. Journal of Pharmacy and Pharmacology 1997; 49: 627–638
   PubMed Web of Science ®Google Scholar
• Litman T, Skovsgaard T, Stein WD. Pumping of drugs by P-glycoprotein: A two-step process?. Journal of Pharmacology and Experimental Therapy 2003; 307: 846–853
   PubMed Web of Science ®Google Scholar
• Luo FR, Paranjpe PV, Guo A, Rubin E, Sinko P. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1. Drug Metabolism and Disposition 2002; 30: 763–770
   PubMed Web of Science ®Google Scholar
• Naruhashi K, Tamai I, Inoue N, Muraoka H, Sai Y, Suzuki N, Tsuji A. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats. Antimicrobial Agents and Chemotherapy 2002; 46: 344–349
   PubMed Web of Science ®Google Scholar
• Pade V, Stavchansky S. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharmacology Research 1997; 14: 1210–1215
   PubMed Web of Science ®Google Scholar
• Raeissi SD, Hidalgo IJ, Segura-Aguilar J, Artursson P. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. Pharmacology Research 1999; 16: 625–632
   PubMed Web of Science ®Google Scholar
• Ramon J, Dautrey S, Farinoti R, Carbon C, Rubinstein E. Intestinal elimination of ciprofloxacin in rabbits. Antimicrobial Agents and Chemotherapy 1994; 38: 757–760
   PubMed Web of Science ®Google Scholar
• Rohwedder R, Bergan T, Thorsteinsson SB, Scholl H. Transintestinal elimination of ciprofloxacin. Chemotherapy 1990; 36: 77–84
   PubMed Web of Science ®Google Scholar
• Ruiz-Garcia A, Lin H, Pla-Delfina JM, Hu M. Kinetic characterization of secretory transpot of a new ciprofloxacin derivative (CNV 97100) across Caco-2 cell monolayers. Journal of Pharmacology Science 2002; 91: 2511–2519
   PubMed Web of Science ®Google Scholar
• Sanchez-Castano G, Ruiz-Garcia A, Banon N, Bermejo M, Merino V, Freixas J, Garrigues TM, Pla-Delfina JM. Intrinsic absolute bioavailability prediction in rats based on in situ absorption rate constants and/or in vitro partition coefficients: 6-Fluoroquinolones. Journal of Pharmacology Science 2000; 89: 1395–1403
   PubMed Web of Science ®Google Scholar
• Sasabe H, Kato Y, Terasaki T, Tsuji A, Sugiyama Y. Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat. Biopharmacology and Drug Disposition 1999; 20: 151–158
   PubMed Web of Science ®Google Scholar
• Sasabe H, Kato Y, Tsuji A, Sugiyama Y. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat. Journal of Pharmacology and Experimental Therapy 1998; 284: 661–668
   PubMed Web of Science ®Google Scholar
• Shapiro AB, Fox K, Lam P, Ling V. Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. European Journal of Biochemistry 1999; 259: 841–850
   PubMedGoogle Scholar
• Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. Journal of Pharmacology and Experimental Therapy 2001; 299: 164–170
   PubMed Web of Science ®Google Scholar
• Talens-Visconti R, Garrigues TM, Canton E, Freixas J, Martin-Villodre A, Pla-Delfina JM. Activity–bioavailability balance in oral drug development for a selected group of 6-fluoroquinolones. Journal of Pharmacology Science 2002; 91: 2452–2464
   PubMed Web of Science ®Google Scholar
• Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). Journal of Pharmacology and Experimental Therapy 1992; 263: 840–845
   PubMed Web of Science ®Google Scholar
• Tran TT, Mittal A, Aldinger T, Polli JW, Ayrton A, Ellens H, Bentz J. The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells. Biophysics Journal 2005; 88: 715–738
   PubMed Web of Science ®Google Scholar
• Tran TT, Mittal A, Gales T, Maleeff B, Aldinger T, Polli JW, Ayrton A, Ellens H, Bentz J. Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrier. Journal of Pharmacology Science 2004; 93: 2108–2123
   PubMed Web of Science ®Google Scholar
• Troutman MD, Thakker DR. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: Asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharmacology Research 2003a; 20: 1200–1209
   PubMed Web of Science ®Google Scholar
• Troutman MD, Thakker DR. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharmacology Research 2003b; 20: 1210–1224
   PubMed Web of Science ®Google Scholar
• Van IS, Maier O, Van der Wouden JM, Hoekstra D. The subapical compartment and its role in intracellular trafficking and cell polarity. Journal of Cell Physiology 2000; 184: 151–160
   PubMed Web of Science ®Google Scholar
• Williams GC, Liu A, Knipp G, Sinko PJ. Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrobial Agents and Chemotherapy 2002; 46: 3456–3462
   PubMed Web of Science ®Google Scholar
• Zeidel ML. Low permeabilities of apical membranes of barrier epithelia: What makes watertight membranes watertight?. American Journal of Physiology 1996; 271: F243–F245
   PubMed Web of Science ®Google Scholar